US Patent Issued to FORMA Therapeutics on July 8 for "Inhibiting cyclic AMP-responsive element-binding protein (CREB)" (Massachusetts, Connecticut Inventors)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,351,577, issued on July 8, was assigned to FORMA Therapeutics Inc. (Watertown, Mass.).

"Inhibiting cyclic AMP-responsive element-binding protein (CREB)" was invented by Shawn E. R. Schiller (Haverhill, Mass.), Torsten Herbertz (Watertown, Mass.), Hongbin Li (Madison, Conn.), Bradford Graves (Watertown, Mass.), Steven Mischke (Waltham, Mass.), Angela V. West (Watertown, Mass.), Anna Ericsson (Shrewsbury, Mass.) and Jennifer R. Downing (Watertown, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to inhibitors of the CBP/p300 family of bromodomains. The compounds can be useful in the treatment of disease or disorders a...